162 related articles for article (PubMed ID: 33010878)
1. Association between age and disease specific mortality in medullary thyroid cancer.
Sahli ZT; Canner JK; Zeiger MA; Mathur A
Am J Surg; 2021 Feb; 221(2):478-484. PubMed ID: 33010878
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
4. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
5. Treatment Variation in Older Adults With Differentiated Thyroid Cancer.
Sutton W; Canner JK; Segev DL; Zeiger MA; Mathur A
J Surg Res; 2020 Oct; 254():154-164. PubMed ID: 32445931
[TBL] [Abstract][Full Text] [Related]
6. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
7. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.
Randle RW; Balentine CJ; Leverson GE; Havlena JA; Sippel RS; Schneider DF; Pitt SC
Surgery; 2017 Jan; 161(1):137-146. PubMed ID: 27842913
[TBL] [Abstract][Full Text] [Related]
8. Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines.
Dyhdalo KS; Chute DJ
Cancer Cytopathol; 2018 Jun; 126(6):397-405. PubMed ID: 29579362
[TBL] [Abstract][Full Text] [Related]
9. Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea.
Ahn HY; Chae JE; Moon H; Noh J; Park YJ; Kim SG
Endocrinol Metab (Seoul); 2020 Dec; 35(4):811-819. PubMed ID: 33212545
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
11. The Benefit of Primary Tumor Surgical Resection in Distant Metastatic Carcinomas of the Thyroid.
Elsamna ST; Suri P; Mir GS; Roden DF; Paskhover B
Laryngoscope; 2021 May; 131(5):1026-1034. PubMed ID: 32865854
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
13. Risk and survival of patients with medullary thyroid cancer: National perspective.
Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
[TBL] [Abstract][Full Text] [Related]
14. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
15. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
16. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM
Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709
[No Abstract] [Full Text] [Related]
17. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
18. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Jin M; Megwalu UC; Noel JE
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
[TBL] [Abstract][Full Text] [Related]
19. Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.
Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Stang MT; Roman SA; Sosa JA; Scheri RP
Surgery; 2019 Nov; 166(5):895-900. PubMed ID: 31288935
[TBL] [Abstract][Full Text] [Related]
20. National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.
Chang EHE; Lutfi W; Feinglass J; Reiher AE; Moo-Young T; Bhayani MK
World J Surg; 2016 Dec; 40(12):2930-2940. PubMed ID: 27447700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]